We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Signature Odor of Parkinson's Disease Discovered

By LabMedica International staff writers
Posted on 02 Apr 2019
Parkinson's disease is a neurodegenerative disorder that leads to progressive brain cell death and extensive loss of motor function. More...
Despite many investigations being conducted on this disease, there are no definitive diagnostic tests currently available.

Volatile organic compounds (VOCs) are often associated with characteristic odors, although some volatiles may also be odorless. The term “volatilome” describes the entirety of the volatile organic and inorganic compounds that may originate from any organism, or object, which may be analytically characterized.

A team of biochemists and other scientists working with the University of Manchester (Manchester, UK) collected sebum samples, an oily or waxy matter secreted by sebaceous glands, using gauze to swab the upper backs of more than 60 subjects, both with and without Parkinson's disease (PD). There were 43 PD subjects and 21 controls, and an independent validation cohort of 31.

A dynamic headspace (DHS) gas chromatography–mass spectrometry (GC–MS) method was developed for the analysis of gauze swabs, which contained sampled participant sebum. DHS is a sample preparation capability for subsequent GC application using the GERSTEL MultiPurpose sampler that concentrates VOCs from liquid or solid samples. The GC analysis was performed on an Agilent GC 7890B coupled to an Agilent MSD 5977B.

The team showed that the data revealed the presence of hippuric acid, eicosane and octadecanal, which indicate the altered levels of neurotransmitters found in Parkinson's patients, along with several other biomarkers for the disease. There were no significant differences observed between PD participants on medication and drug naïve PD participants for all measured volatiles, indicating that the majority of the analyzed volatilome and by inference sebum are unlikely to contain drug metabolites associated with PD medication.

The authors concluded that their study highlights the potential of comprehensive analysis of sebum from PD patients and raises the possibility that individuals can be screened noninvasively based on targeted analysis for these volatile biomarkers. The study was published on March 20, 2019, in the journal ACS Central Science.

Related Links:
University of Manchester


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.